Burleson & Company, LLC Agenus Inc Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
Shares
2 transactions
Others Institutions Holding AGEN
# of Institutions
8Shares Held
2.07MCall Options Held
0Put Options Held
0-
Morgan Jess S & CO Inc1.3MShares$21.7 Million2.32% of portfolio
-
Putnam Investments LLC Boston, MA515KShares$8.59 Million0.0% of portfolio
-
First Command Bank70.6KShares$1.18 Million0.01% of portfolio
-
First Command Financial Services, Inc.70.6KShares$1.18 Million0.01% of portfolio
-
Ethic Inc. New York, NY70.6KShares$1.18 Million0.03% of portfolio
About AGENUS INC
- Ticker AGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 283,163,008
- Market Cap $4.73B
- Description
- Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...